OBJECTIVES: To review the current practice in the diagnosis, monitoring and management of TCM in @entity510 @entity1 at our tertiary referral institution and the relevant literature, and to evaluate the effect of certain treatment modalities on the outcome of those @entity1 . @entity1 AND METHODS: A retrospective institutional chart review of 800 @entity1 with @entity439 @entity510 from 2007 to 2014. Eighteen @entity1 were identified to have both @entity439 @entity510 and TCM based on echocardiogram. Demographic data, clinical parameters, radiographic findings, treatment modalities, and laboratory results were analyzed. RESULTS: The incidence of typical TCM in our @entity1 was 2.2%. Mortality rate of TCM in @entity510 was 22% compared to the total mortality rate of all non-traumatic @entity510 @entity1 of 15% in our institution over the same time period. Use of beta blockers prior to or after the diagnosis of TCM did not seem to affect their outcome. Majority of @entity1 (61%) were on vasopressors prior to the diagnosis of TCM. Of those, 73% had good outcomes. Even after the diagnosis of TCM, good outcomes were observed in 6 of 7 @entity1 who remained on vasopressors. CONCLUSION: Despite the general agreement on the importance of the avoidance of vasopressors in TCM, our experience showed that the use of vasopressors is safe in these @entity1 . The use of beta blockers in our @entity1 was not associated with significantly better outcomes despite multiple previous reports on beta blocker usage in TCM.

Takotsubo cardiomyopathy in XXXX : Institutional experience and literature review.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity439 :: ('MESH:D000783', 'Disease') :: ['aneurysmal'] @entity510 :: ('MESH:D013345', 'Disease') :: ['SAH']
@entity510 :: (MESH:D013345,Disease) :: ['aneurysmal subarachnoid hemorrhage']
